Global Needle-Free Injection Systems Market to Grow at a CAGR of 16%

Introduction

A cutting-edge method of administering various medications to patients without puncturing their skin with a conventional needle is the needle-free injection system. The ability of technically advanced needle-free injection systems to provide highly viscous medicine formulations that cannot be administered by conventional needle and syringe systems is another advantage of the technology. Future medicine administration will be almost painless and incredibly effective due to this technology. The World Health Organization and the Centers for Disease Control and Prevention, among others, are supporting this technology.

Market Dynamics

Communicable Diseases Brought on by Needle Stick Injuries Drive the Market

Despite the fact that widespread precautions and safety-conscious needle designs have reduced needlestick injuries, they nevertheless still occur. The CDC has developed a model that medical professionals can use to decide when to start antiretroviral therapy. The most affected employees were the nurses because syringe disposal was so widespread. In contrast, there was a higher frequency of NSIs among doctors, where surgical gadgets were the main cause. Because of the increasing prevalence of communicable diseases brought on by needle stick injuries, the market is anticipated to grow more quickly over the projected period.

Regional Analysis

North America is likely to hold the largest share of the market during the forecast period. The industry is seeing increased demand due to the rising demand for immunization among pediatric patients. The market in the region is growing due to a number of factors, including a rise in biologics demand, technological advancements, mergers and acquisitions by significant market participants, favorable reimbursement policies, rising healthcare costs, and regulatory approvals of new injectable systems. It is well known that serious needlestick injuries frequently occur in hospital settings. Since millions of healthcare workers in North America regularly use needles, the risk of needlestick injuries is a constant worry. Nurses, emergency room personnel, lab personnel, and surgeons are among the healthcare workers most susceptible to needle stick injuries. Needlestick injuries still occur even though every hospital has procedures in place for the proper handling and disposal of needles, as well as the most recently developed safety-conscious needles. The market is expected to grow during the forecast year due to the increase in needlestick injuries in the region.

Europe is expected to be the second leading region in the global needle-free injection system market. The prevalence of diabetes is rising, which is accelerating the development of insulin delivery systems without needles. For instance, the World Health Organization estimates that 4.1 million people in the UK have diabetes. Additionally, favorable reimbursement policies, growing healthcare expenditures, and regulatory approvals of advanced injectable systems are driving market expansion in Europe.

Asia Pacific (APAC) is expected to be the fastest-growing region during the forecast period. This is explained by the rising incidence of communicable infections and chronic illnesses in the area as a result of needlestick injuries. Diabetes prevalence is rising in India and China, which is accelerating market expansion. Because it is utilized in mass vaccination programs, eliminating the risk of needle stick injuries and preventing other complications, such as those caused by the repetitive use of a single needle, the technique is becoming increasingly well-liked in developing nations in the region.

LAMEA is expected to witness sluggish growth in the global market during the forecast period. This is a result of Africa's inadequate healthcare system and its slow economic growth. However, the Middle East's developing healthcare systems and high standard of living are propelling the region's expansion. The removal of needle dangers and healthcare expense savings are increasing the demand for these systems. Recent improvements in these systems have greatly increased demand. However, factors including a shortage of competent professionals and the restricted use of needle-free injection methods for drug administration will limit the market's growth in the area.

Key Highlights

• The global needle-free injection systems market was valued at USD 18.9 billion in 2022. It is projected to reach USD 71.8 billion by 2031, growing with a CAGR of 16% during the forecast period (2023–2031).
• Based on product type, the market is segmented into fillable needle-free injectors and prefilled needle-free injectors. Prefilled syringe segment is expected to grow with the highest CAGR.
• On the basis of technology, the needle-free injection systems market is segmented into spring-based needle-free injectors, vibration-based needle-free injectors, laser-powered needle-free injectors, and jet-based needle-free injectors.
• On the basis of the type of medication, the needle-free injection systems market is segmented into Projectile/depot-based needle-free injectors, powder-based needle-free injectors, and Liquid-based needle-free injectors.
• Based on the site of delivery, the market is segmented into intradermal injectors, intramuscular injectors, and subcutaneous injectors.
• Based on the application, the market is segmented into vaccine needle-free delivery, pain management needle-free delivery, oncology needle-free delivery, insulin needle-free delivery, and other applications.
• Based on end-user, the market is segmented into clinics and hospitals, home care settings, pharmaceutical, and biotechnology companies, research laboratories, and other end users.

Competitive Players

Competitive Analysis

Some key players in the needle-free injection systems market are Endo International plc, Antares Pharma Inc., PenJet Corporation, Bioject Medical Technologies Inc., Medical International Technology Inc., PharmaJet, National Medical Products Inc., Valeritas Inc., INJEX Pharma AG, European Pharma Group, Crossject SA.

Recent Developments

Market News

• In October 2022, A distributorship agreement was reached by Science-Link Trading, a business whose goal is to assist in the commercialization of emerging disruptive technologies, and NuGen Medical Devices Inc., a pioneer in needle-free medicine delivery. The Agreement commits to 34,000 InsuJet devices over five years and includes extra accessories.
• In June 2022, The latest prototype of NovaXS Biotech's smart medical device for needle-free injectable therapy was unveiled. Telosis, a patent-pending device from NovaXS, was created to deliver a narrow stream of medication without a needle in 0.3 seconds and evaluate injection data to allow smarter medical choices.

Segmentation

Global Needle-Free Injection Systems Market Segmentation

By Product

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

By Technology

• Jet-Based Needle-Free Injectors
• Spring-Based Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

By Usability

• Reusable Needle-Free Injectors
• Disposable Needle-Free Injectors

By Type of Medication

• Liquid-based needle-free injectors
• Powder-based needle-free injectors
• Projectile/depot-based needle-free injectors

By Site of Delivery

• Intra dermal injectors
• Intramuscular injectors
• Subcutaneous injectors

By Application

• Vaccine Needle-free delivery
• Insulin Needle-free delivery
• Pain Management Needle-free delivery
• Oncology Needle-free delivery
• Others applications

By End User

• Hospitals and Clinics
• Homecare Settings
• Research Laboratories
• Pharmaceutical and Biotechnology companies
• Other End Users

By Region

• North America
• Europe
• Asia Pacific
• LAMEA